Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial Results

NewMediaWire

27 Feb

SOUTH ORANGE, NJ - February 26, 2025 (NEWMEDIAWIRE) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its fourth-quarter and fiscal year financial results on Thursday, March 6, 2025 after market close and will host a conference call that same day at 4:30pm ET.

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

Alternatively, a replay of the call may be accessed until March 13, 2025 at 1 (877) 344-7529 or
1 (412) 317-0088 for international callers and entering replay access code: 1414130.

About Nephros

Nephros is a leading provider of filtration products to the medical, commercial, and industrial markets, offering a wide range of solutions that deliver superior filtration performance. With its advanced hollow-fiber technology and effective commercial filter media, Nephros products help protect against waterborne contaminants, ensuring the highest level of water quality.

For more information about Nephros, please visit us at nephros.com.

Investor Relations Contacts:

Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Robert Banks, CEO
Nephros, Inc.
(201) 343-5202 x110
robert.banks@nephros.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2514289868"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514289868\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2514289868?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 05:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2514289868","market":"us","top_or_hot":-1,"title":"Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial Results","media":"NewMediaWire","content":"<html><body><p>SOUTH ORANGE, NJ - February 26, 2025 (NEWMEDIAWIRE) - <a href=\"https://laohu8.com/S/NEPH\">Nephros, Inc.</a> (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its fourth-quarter and fiscal year financial results on Thursday, March 6, 2025 after market close and will host a conference call that same day at 4:30pm ET.</p>\n<p>Participants may dial into the call as follows:<br/>Domestic access: 1 (844) 808-7106<br/>International access: 1 (412) 317-5285</p>\n<p>Upon joining, please ask to be joined into the Nephros conference call.</p>\n<p>An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.</p>\n<p>Alternatively, a replay of the call may be accessed until March 13, 2025 at 1 (877) 344-7529 or <br/>1 (412) 317-0088 for international callers and entering replay access code: 1414130.</p>\n<p><strong>About Nephros</strong></p>\n<p>Nephros is a leading provider of filtration products to the medical, commercial, and industrial markets, offering a wide range of solutions that deliver superior filtration performance. With its advanced hollow-fiber technology and effective commercial filter media, Nephros products help protect against waterborne contaminants, ensuring the highest level of water quality.</p>\n<p>For more information about Nephros, please visit us at nephros.com.</p>\n<p><strong>Investor Relations Contacts:</strong></p>\n<p>Kirin Smith, President<br/>PCG Advisory, Inc.<br/>(646) 823-8656<br/>ksmith@pcgadvisory.com</p>\n<p>Robert Banks, CEO<br/>Nephros, Inc.<br/>(201) 343-5202 x110<br/>robert.banks@nephros.com</p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-27 05:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/nephros-schedules-conference-call-fourth-210000359.html><strong>NewMediaWire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SOUTH ORANGE, NJ - February 26, 2025 (NEWMEDIAWIRE) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today ...</p>\n\n<a href=\"https://finance.yahoo.com/news/nephros-schedules-conference-call-fourth-210000359.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4161","symbol_name":"工业机械","start_time":0,"source_url":"https://finance.yahoo.com/news/nephros-schedules-conference-call-fourth-210000359.html","article_id":"2514289868","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514289868","pubTimestamp":1740603600,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"SOUTH ORANGE, NJ - February 26, 2025  - Nephros, Inc. , a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its fourth-quarter and fiscal year financial results on Thursday, March 6, 2025 after market close and will host a conference call that same day at 4:30pm ET.Participants may dial into the call as follows:Domestic access: 1  808-7106International access: 1  317-5285. Upon joining, please ask to be joined into the Nephros conference call.An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.Alternatively, a replay of the call may be accessed until March 13, 2025 at 1  344-7529 or 1  317-0088 for international callers and entering replay access code: 1414130.Nephros is a leading provider of filtration products to the medical, commercial, and industrial markets, offering a wide range of solutions that deliver superior filtration performan","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4161":"工业机械","BK4191":"家用电器","NEPH":"Nephros, Inc."},"translate_title":"Nephros计划电话会议公布第四季度和2024财年财务业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NEPH":0.9},"content_text":"SOUTH ORANGE, NJ - February 26, 2025 (NEWMEDIAWIRE) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its fourth-quarter and fiscal year financial results on Thursday, March 6, 2025 after market close and will host a conference call that same day at 4:30pm ET.\nParticipants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285\nUpon joining, please ask to be joined into the Nephros conference call.\nAn audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.\nAlternatively, a replay of the call may be accessed until March 13, 2025 at 1 (877) 344-7529 or 1 (412) 317-0088 for international callers and entering replay access code: 1414130.\nAbout Nephros\nNephros is a leading provider of filtration products to the medical, commercial, and industrial markets, offering a wide range of solutions that deliver superior filtration performance. With its advanced hollow-fiber technology and effective commercial filter media, Nephros products help protect against waterborne contaminants, ensuring the highest level of water quality.\nFor more information about Nephros, please visit us at nephros.com.\nInvestor Relations Contacts:\nKirin Smith, PresidentPCG Advisory, Inc.(646) 823-8656ksmith@pcgadvisory.com\nRobert Banks, CEONephros, Inc.(201) 343-5202 x110robert.banks@nephros.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}